版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
hexahydroxycyclohexane六羥基環(huán)己烷ultrasonography超聲波檢查法titrimetric滴定(分析)的superinfection重復(fù)感染,二重感染interventricular室間的visceroptosis內(nèi)臟下垂lymphocyte淋巴細(xì)胞tachycardia心動(dòng)過(guò)速topoisomerase拓?fù)洚悩?gòu)酶phenobarbital苯巴比妥epidermitis表皮炎fibroblastic成纖維細(xì)胞的dehydroandrosterone脫氫雄甾酮erythropoietin(促)紅細(xì)胞生成素intravenous靜脈內(nèi)的decarboxylase
脫羧酶propanetriol丙三醇;甘油p-aminophenylsulfonamide對(duì)氨基苯磺酰胺neuropathological神經(jīng)病理學(xué)的morphocytology細(xì)胞形態(tài)學(xué)benzaldehyde苯甲醛hydrophobicity疏水性cycloalkene環(huán)烯烴macromolecular大分子的cardiovasculology心血管學(xué)sympatholytic交感神經(jīng)阻滯的(藥)transconfiguration反式構(gòu)型thrombopoiesis血栓形成;血小板生成carcinogenesis致癌作用,癌發(fā)生levoisomer左旋異構(gòu)體nucleophilic親核的euthanasia安樂(lè)死pharmacopoeia藥典nitroglycerin硝酸甘油splenorenopexy脾腎固定術(shù)polysaccharide多糖isoantibody同種(族)抗體heterogenous異質(zhì)的,異源的,異種的antibiotic抗菌的;抗生素carcinogenesis致癌作用,癌發(fā)生teratogenic致畸的osteoporosis骨質(zhì)疏松parasympathetic副交感神經(jīng)的antihypercholesterolemic抗高膽甾醇血的(藥)pathophysiology病理生理學(xué)oliguria少尿euchromosome常染色體overdose過(guò)量(用藥)electroencephalogram腦電圖chromatography色譜(分析)法paracetamol對(duì)乙酰氨基酚,撲熱息痛hyperplasia增生,畸形生長(zhǎng)arthrectomy關(guān)節(jié)切除術(shù)chromatogram色譜圖peridentitis牙周炎leuc(k)ocyte白細(xì)胞oxidoreductase氧化還原酶retrotranscriptase反轉(zhuǎn)錄酶homeostasis體內(nèi)平衡,自身穩(wěn)定levodopa左旋多巴endotoxin內(nèi)毒素lipophobic疏脂的contraindication禁忌癥neurofibroma神經(jīng)纖維瘤percutaneous經(jīng)皮的anticholinesterase抗膽堿酯酶electrocardiogram心電圖nitrobenzene硝基苯spectrophotometry分光光度法cis-trans-isomer順?lè)串悩?gòu)體enterogastritis腸胃炎o(hù)torhinolaryngology耳鼻喉科學(xué)esophagogastrostomy食管胃吻合術(shù)covalent共價(jià)的laparotomy剖腹術(shù)morbidostatic阻止疾病的electrocardiogram心電圖nitrobenzene硝基苯nitroglycerin硝酸甘油antianemic
抗貧血的(藥)deoxyribotide脫氧核(糖核)苷酸antianemic
抗貧血的(藥)deoxyribotide脫氧核(糖核)苷酸heterocyclic
雜環(huán)的endoscopy內(nèi)窺鏡檢查biopharmaceutics生物藥劑學(xué)macroglossia巨舌l(xiāng)eucolytic白細(xì)胞溶解的※nano-納,毫微,10-9※micro-微,10-6※milli-毫,10-3※centi-厘,10-2※deci-分,10-1※deca-十,10※kilo-千,103※-liter升※meter米※gram克
microlitermicrometermicrogrammillilitermillimetermilligramdeciliterdecimeterdecigramnanoliternanometernanogramcentilitercentimetercentigramdecaliterdecameterdecagramkiloliterkilometerkilogram★
Allcarbohydrate碳水化合物foods,astheyaredigested,eventuallybreakdownintosimplesugars(monose),suchasglucoseandfructose.★Sucroseisadisaccharide(diose)composedofonemolecule分子ofglucoseandonemoleculeoffructose.★Themostimportantrepresentativesofdisaccharidesaresucrose,lactose,maltoseandcellobiose.★Glucosewithasix-carbon-atomaldehydesugaristermedanaldohexose.★Maltasecancatalyze催化thehydrolysis水解作用ofmaltosetotwoglucoses.acetate醋酸鹽;乙酸鹽carbonate碳酸鹽
◆calcium
carbonate
碳酸鈣
◆barium
carbonate
碳酸鋇bicarbonate碳酸氫鹽
◆sodiumbicarbonate碳酸氫鈉;小蘇打
ammoniumdihydrogenphosphate
磷酸二氫銨NH4H2PO4diammoniumhydrogenphosphate
磷酸氫二銨(NH4)2HPO4ammoniumacetate醋酸銨,乙酸銨
potassiumdihydrogenphosphate磷酸二氫鉀
dipotassium
phosphate磷酸氫二鉀
★
Nitric
(含)氮的oxide(NO)
plays
animportant
role
in
cardiovascular心血管的system.Nitric
oxide
synthase(NOS)is
thekeyenzymeduringthe
synthesis合成process
ofNO.
★Amylase
and
lipase
valuestypically
willbe
elevated
in
the
early
or
acute
stage
ofpancreatitis.pancreas
['p??kr??s]胰腺[,p??kr??'ta?t?s]胰腺炎
★The
salicylate水楊酸
hydroxylase羥化酶can
catalyze
thedecarboxylation脫羧andhydroxylation羥基化of
salicylate
toform
catechol.★
Lowtemperature
reducedthe
activities
ofthe
enzymes
related
to
fiber
synthesis,includingphenylalanine苯(基)丙氨酸deaminase脫氨(基)酶,polyphenol
oxidase,
cinnamyl
alcoholdehydrogenase肉桂醇脫氫酶and
peroxidase過(guò)氧化物酶.
★Someimportantcatecholamines兒茶酚胺類suchasepinephrine腎上腺素,norepinephrine
去甲腎上腺素anddopaminecanbemetabolized代謝bycatechol-O-methyltransferase(COMT)andmonoamineoxidase(MAO).★
Aldosteroneisahormonesecretedbytheadrenal
cortex腎上腺皮質(zhì)thatregulateselectrolyte電解質(zhì)andwaterbalancebyincreasingtherenalretention保留,滯留ofsodium鈉andtheexcretion
排泄(物);分泌(物)ofpotassium鉀.
★Acetylcholineisakindofneurotransmitters神經(jīng)遞質(zhì).
Itissynthesized合成inthecytoplasm細(xì)胞質(zhì)fromacetyl-CoAandcholine膽堿throughthecatalytic起催化作用的actionoftheenzyme-cholineacetyltransferase(ChAT)膽堿乙酰轉(zhuǎn)移酶.Acetyl-CoAissynthesizedinmitochondria線粒體whicharepresentinlargenumbersinthenerveending.Acetylcholinesterase(AChE)isanenzymethatcatalyzesthehydrolysisofacetylcholinetocholineandacetate.Aspirin(acetylsalicylicacid;ASA)◆Clinicaluses
臨床應(yīng)用:Analgesia鎮(zhèn)痛,Antipyresis解熱,andAnti-inflammatory抗炎Effects★Aspirinisemployedformildtomoderatepainofvariedoriginbutisnoteffectiveforseverevisceral內(nèi)臟的
pain.AspirinandotherNSAIDs非甾體抗炎藥(NonsteroidalAnti-inflammatoryDrugs)havebeencombinedwithopioidanalgesics阿片類鎮(zhèn)痛藥fortreatmentofcancerpain,wheretheiranti-inflammatoryeffectsactsynergistically協(xié)同地
withtheopioidstoenhanceanalgesia鎮(zhèn)痛.High-dosesalicylateareeffectivefortreatmentofrheumaticfever風(fēng)濕熱,rheumatoid類風(fēng)濕性,arthritis
關(guān)節(jié)炎andotherinflammatoryjoint關(guān)節(jié)conditions.B.OtherEffects★Aspirindecreasestheincidence發(fā)病率oftransientischemicattacks短暫性腦缺血發(fā)作,unstableangina不穩(wěn)定型心絞痛,coronaryarterythrombosis冠狀動(dòng)脈血栓形成withmyocardialinfarction心肌梗死,心肌梗塞,andthrombosis血栓形成aftercoronaryarterybypassgrafting冠狀動(dòng)脈旁路移植術(shù).Epidemiologicstudies流行病學(xué)研究
suggestthatlong-termuseofaspirinatlowdosageisassociatedwithalowerincidenceofcoloncancer結(jié)腸癌,possiblyrelatedtoitscyclooxygenase(COX)-inhibitingeffects.
★
Sodiumnitroprussideisapowerfulparenterally(parenteral
[p?'rent(?)r(?)l]腸胃外的,不經(jīng)腸道的,注射用藥物的)
administered
給藥vasodilator血管舒張藥thatisusedintreatinghypertensiveemergencies高血壓急癥aswellassevereheartfailure.★
Nitroprussidedilates擴(kuò)大botharterial動(dòng)脈的andvenous靜脈的vessels,resultinginreducedperipheralvascularresistance外周血管阻力
andvenousreturn.Theactionoccursasaresultofactivationofguanylylcyclase鳥(niǎo)苷酸環(huán)化酶,eitherviareleaseofnitricoxideorbydirectstimulationoftheenzyme.primaryamine伯胺,一級(jí)胺RNH2
secondaryamine仲胺,二級(jí)胺R2NHtertiaryamine叔胺,三級(jí)胺R3Nquaternaryamine季銨鹽,四級(jí)銨鹽類R4N+X-
methylamine,aminomethane甲胺gasdimethylamine二甲胺gasethylamine,aminoethane乙胺liquiddiethylamine二乙胺liquid2-methoxyethylamine2-甲氧基乙胺
cyclohexylamine環(huán)己胺
diphenylamine二苯胺
trimethylamine三甲胺
triethylamine三乙胺
diethanolamine二乙醇胺(HOCH2CH2)2NHtriethanolamine三乙醇胺(HOCH2CH2)3Nphenylethylamine苯乙胺['f?n?l,iθa?l?'min]phenylethanolamine苯乙醇胺
furan呋喃tetrahydrofuran四氫呋喃
imidazole咪唑pyrazole吡唑
thiazole噻唑isothiazole異噻唑
isoxazole異噁唑oxazole噁唑
pyran吡喃pyridine
吡啶
pyrimidine嘧啶
purine嘌呤quinoline喹啉
sulfate硫酸鹽['s?lfeit]◆aluminiumsulfate硫酸鋁
◆bariumsulfatesulfite亞硫酸鹽
◆potassium,sodium+sulfitenitrite
亞硝酸鹽◆sodiumnitrite
thiosulfate硫代硫酸鹽
◆sodiumthiosulfate,Na2S2O3
sulfur硫(磺)◆sulfurdioxidesulfate硫酸鹽
halogen鹵素
halogenelements鹵族元素
FluorineChlorineBromineIodinebisulfate硫酸氫鹽◆ammoniumbisulfateNH4HSO4sulfite亞硫酸鹽◆sodium,potassium+sulfite
bisulfite亞硫酸氫鹽
◆potassiumbisulfiteKHSO3
sulfide硫化物
◆hydrogensulfide
H2S
★
Thereare
six
common
airpollutants:
ozone臭氧,
nitrogen
dioxide,carbonmonoxide,lead鉛,
sulfur
dioxide
and
particulatematter粉塵.
★Hydrogen
sulfide
is
a
molecule
consisting
of
twohydrogen
atoms
and
onesulfur
atom.
sulfone砜;磺基[◆dimethylsulfone,MSM二甲基砜CH3·SO2·CH3◆diethylsulfone二乙基砜(C2H5)2SO2
◆ethylphenylsulfone苯乙砜C6H5·SO2·C2H5sulfoxide亞砜◆dimethylsulfoxide,DMSO二甲基亞砜(CH3)2SO◆diethylsulfoxide,DESO二乙基亞砜cyanide氰化物
◆hydrogencyanide氫氰酸HCN◆sodium,potassium+cyanideNaCN,KCN◆potassiumferricyanide鐵氰化鉀K3[Fe(CN)6]◆potassiumferrocyanide亞鐵氰化鉀arsenictrioxide三氧化二砷
★Pharmacologyisanimportantsubjectstudyingtheinteractionsthatoccurbetweenalivingorganismandsomechemicalsandtheeffectsofthosechemicalsonthenormalandabnormalbiochemicalfunctionsoftheorganism.Thetwomainareasofpharmacologyarepharmacodynamicsandpharmacokinetics.Pharmacologyisanexperimentaldiscipline,whichdealswithhowdrugsinteractwithinbiologicalsystemsbyperformingexperimentalstudiesinvitro在體外,在試管內(nèi),exvivo間接體內(nèi)法,體外andinvivo在體內(nèi).
★Pharmacologyresearchisdividedintopre-clinicalandclinicaltrials.Theformerinvolvesinvitro(testtubeorcellculture)andinvivo(animal)experiments,whichproducecriticalpreliminaryresults.Theseresultsformthebasisforevaluationofdrugcandidatesandtheirpotentialforfurtherdevelopmentintonewdrugs.Thelatteristheclinicaltestingofdrugcandidatesinhumansubjects,thiswillnormallyproceedthroughfourphasesofclinicalstudies.
★Drugdevelopmentsconsiderationsarefirst,thesafetyofthedrugs;second,theeffectivenessoftreatmentsandthird,thehighselectivityofdrugs.Intheprocessofdrugdevelopments,pharmacologyplaysacrucialroleintargetdiscoveryandevaluation,drugmechanismelucidation闡明,drugstructuraloptimization,targetproteinrecognition,drugsynergism協(xié)同作用andtoxicitiesassessment.Pharmacokinetics(PK)★
Pharmacokinetics(PK)includestwointerrelatedprocesses.Thefirstprocessisdrugabsorption,distribution,metabolism(biotransformation)andexcretion(ADME),andanotheristheevaluationofthequantitativekineticprocessesofADMEbykineticprinciplesandmathematicalmodels.★Absorptionisthepassageofthedrugfromitssiteofadministration給藥intotheblood.Besidesgastrointestinaltract胃腸道thereareseveralotherroutesforabsorptionsuchasintramuscular肌肉內(nèi)的orsubcutaneous皮下的adminstration,andattimes,throughlungorskin,etc.Distributionisthedeliveryofdrugtothetissue.Toreachitssiteofaction,adrugmustcrossanumberofbiologicalbarriers(blood-brainbarrier,placental
barrier胎盤屏障,etc)andthepredominantlylipidmembranes脂質(zhì)膜.Bothmetabolismandexcretioncanbeviewedasprocessesresponsibleforeliminationofdrug(parentandmetabolite
代謝物)fromthebody.Drugmetabolismchangesthechemicalstructureofadrug,thisaltereddrugproductiscalledadrugmetabolite,whichisfrequentlybutnotuniversallylesspharmacologicallyactive.Metabolismalsorendersthedrugcompoundmorewatersolubleandthereforemoreeasilyexcreted.TheADMEprocessesofadruginvolveitspassageacrossacellmembrane.Thephysicalandchemicalpropertiesofthedrugmoleculesandthecellmembranesthataffectthistransferarethuscriticalinunderstandingthedisposition處置ofdrugsinthehumanbody.
Therearetwowaysthatdrugmoleculespassthroughthemembrane:eitherbypassiveprocessesorbymechanismsinvolvingtheactiveparticipaitonofcomponentsofthemembrane.
★
Mathematicalmodelsareoftenusedtodescribethekinetics動(dòng)力學(xué)ofdrugelimination.Thesemainlyincludefirstorderkinetics,zeroorderkineticsandMichaelis-MentenkineticswithimportantPK
parameters參數(shù)[p?'r?m?t?(r)z]suchast1/2,Vd,AUC,F,CLtot,Cssetc.
PhaseⅠandphaseⅡMetabolism
★DrugbiotransformationreactionsareclassifiedaseitherphaseⅠfunctionalization功能化(oxidation氧化,reduction還原
andhydrolysis)reactionsorphaseⅡbiosynthetic生物合成的(conjugation接合)reactions.PhaseⅠreactionsintroduceafunctionalgroup
官能團(tuán)ontheparentcompound.PhaseⅠreactionsgenerallyresultinthelossofpharmacologicalactivity藥理活性,althoughthereareexamplesofretentionorenhancementofactivity.Inrareinstances,metabolismisassociatedwithanaltered改變了的
pharmacologicalactivity.
Prodrugs前藥arepharmacologicallyinactivecompounds,designedto旨在,目的在于maximize最大化theamountoftheactivespeciesthatreachesitssiteofaction.Inactiveprodrugsareconvertedrapidlytobiologicallyactivemetabolites,oftenbythehydrolysisofanesteroramide
linkage酰胺鍵.Ifnotrapidlyexcretedintotheurine尿,theproductsofphaseⅠbiotransformationreactionscanthenreactwithendogenous內(nèi)源的,內(nèi)生的compoundstoformahighlywatersoluble水溶性的conjugate.
★PhaseⅡconjugationreactionsleadtotheformationofacovalentlinkagebetweenafunctionalgroupontheparentcompoundorphaseⅠmetabolitewithendogenously內(nèi)生地
derivedglucuronicacid葡萄糖醛酸,sulfate,glutathione谷胱甘肽,aminoacids,oracetate.Thesehighlypolarconjugatesaregenerallyinactiveandareexcretedrapidlyintheurineandfeces糞便.Anexampleofanactiveconjugateisthe6-glucuronide葡糖苷酸metaboliteofmorphine
嗎啡,whichisamorepotent更強(qiáng)
analgesic鎮(zhèn)痛藥
thanitsparentcompound.
Thelipids脂類ofhumanplasma血漿aretransportedinmacromolecular大分子的complexes復(fù)合物termedlipoproteins.Anumberofmetabolic
代謝的disordersthatinvolveelevationsinlevelsofanyofthelipoproteinspeciesarethustermedhyperlipoproteinemiasorhyperlipidemias.Thetermhyperlipemiadenotesincreasedlevelsoftriglycerides甘油三脂inplasma.CompetitiveinhibitorsofHMG-CoAreductase(reductase-inhibitors;“statins”他汀類藥物)Thesecompoundsarestructuralanalogs類似物
ofHMG-CoA.Lovastatin洛伐他汀,atorvastatin阿托伐他汀,fluvastatin氟伐他汀,pravastatin普伐他汀,simvastatin辛伐他汀,androsuvastatin瑞舒伐他汀belongtothisclass.TheyaremosteffectiveinreducingLDL.Ithasbecomestandardpracticetoinitiatereductaseinhibitortherapyimmediatelyaftermyocardialinfarction,irrespectiveoflipidlevels.Reductaseinhibitorsareusefulaloneorwithresins,niacin
['na??s?n]煙酸,orezetimibe
依折麥布
inreducinglevelsofLDL.Becausecholesterolbiosynthesisoccurspredominantlyatnight,reductaseinhibitors-exceptatorvastatinandrosuvastatin-shouldbegivenintheeveningifasingledailydoseisused.Absorptiongenerally(withtheexceptionofpravastatin)isenhancedbytakingthedosewithfood.※eu-好,正常,真
euthanasia安樂(lè)死
euchromatin常染色質(zhì)
euchromosome常染色體
euglycemia血糖正常normalbloodglucose
eupepsia消化良好gooddigestioneupnea呼吸正常normalbreathing★L(fēng)ecithin
[‘les?θ?n]卵磷脂may
prove
useful
in
alleviating
減輕the
symptoms
of
Senile
dementia
老年癡呆癥,Alzheimer‘sdisease
阿爾茨海默氏癥and
Tardive
dyskinesia遲發(fā)性運(yùn)動(dòng)障礙.
dysglycemia血糖代謝障礙
dyspnea呼吸困難
dyspepsia消化不良poordigestiondyskinesia運(yùn)動(dòng)障礙
enteropathy腸病intestinaldiseasehepatopathy肝病liverdiseasenephropathy腎病nephrosiscerebropathy腦病cerebrosiscardiopathy心臟病heartdiseaseotopathy耳病
myopathy肌病※-rrhexis裂,破裂a(bǔ)ngiorrhexis血管破裂vesselrupturearteriorrhexis動(dòng)脈破裂a(bǔ)rteryrupturephleborrhexis靜脈破裂venousrupture
cardiorrhexis心臟破裂cardiacrupturehepatorrhexis肝破裂hepaticruptureenterorrhexis腸破裂bowel
rupture※-rrhea流出,分泌,溢出
galactorrhea;lactorrhea乳溢
diarrhea,enterorrhea腹瀉※-rrhage
出血,流血
hemorrhage出血
subarachnoidhemorrhage蛛網(wǎng)膜下出血
postpartumhemorrhage產(chǎn)后出血
※
-rrhagia出血,流血
gastrorrhagia胃出血
gastrichemorrhagehepatorrhagia肝出血
hepatichemorrhageenterorrhagia腸出血
intestinalhemorrhagenephrorrhagia腎出血
renalhemorrhage
arteriorrhagia動(dòng)脈出血
arterialhemorrhage
phleborrhagia靜脈出血
venoushemorrhage
encephalorrhagia腦出血cerebralhemorrhage1.W
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 二零二四年度上海房產(chǎn)買賣合同智能家居系統(tǒng)配套范本3篇
- 2024版鄭州玻璃崗?fù)どa(chǎn)與供應(yīng)鏈管理合同
- 2025年智能電網(wǎng)建設(shè)項(xiàng)目資金投入合同3篇
- 二零二五版豆腐品牌連鎖加盟合同3篇
- 二零二五年度企業(yè)商業(yè)信用貸款還款合同3篇
- 二零二四年醫(yī)療器械生產(chǎn)許可合同
- 2025年綠色建筑項(xiàng)目瓦工力工勞務(wù)分包及節(jié)能減排合同3篇
- 2025年度大型活動(dòng)臨時(shí)演員招募服務(wù)合同4篇
- 年度豆?jié){粉戰(zhàn)略市場(chǎng)規(guī)劃報(bào)告
- 年度電子廚房秤競(jìng)爭(zhēng)策略分析報(bào)告
- 中華人民共和國(guó)保守國(guó)家秘密法實(shí)施條例培訓(xùn)課件
- 管道坡口技術(shù)培訓(xùn)
- OQC培訓(xùn)資料教學(xué)課件
- 2024年8月CCAA國(guó)家注冊(cè)審核員OHSMS職業(yè)健康安全管理體系基礎(chǔ)知識(shí)考試題目含解析
- 體育賽事組織與實(shí)施操作手冊(cè)
- 2024年浙江省公務(wù)員考試結(jié)構(gòu)化面試真題試題試卷答案解析
- 2023年航空公司招聘:機(jī)場(chǎng)安檢員基礎(chǔ)知識(shí)試題(附答案)
- 皮膚儲(chǔ)存新技術(shù)及臨床應(yīng)用
- 《現(xiàn)在完成時(shí)》語(yǔ)法復(fù)習(xí)課件(共44張-)
- 二年級(jí)下冊(cè)語(yǔ)文《第3單元 口語(yǔ)交際:長(zhǎng)大以后做什么》課件
- 2024年遼寧石化職業(yè)技術(shù)學(xué)院?jiǎn)握新殬I(yè)適應(yīng)性測(cè)試題庫(kù)必考題
評(píng)論
0/150
提交評(píng)論